FB2026_03 , released September 17, 2026
Reference Report
Open Close
Reference
Citation
Schludi, M.H., Edbauer, D. (2018). Targeting RNA G-quadruplexes as new treatment strategy for C9orf72 ALS/FTD.  EMBO Mol. Med. 10(1): 4--6.
FlyBase ID
FBrf0264965
Publication Type
Note
Abstract
The recent discovery of a pathogenic expansion of a (GGGGCC)n repeat in the C9orf72 gene in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) led to a burst of mechanistic discoveries. In this issue, Simone et al (2018) describe novel compounds targeting the G‐quadruplex (G‐Q) structure of the (GGGGCC)n repeat RNA that alleviate the hallmarks of C9orf72 disease in patient‐derived neurons and increase survival in a Drosophila model. Lack of overt off‐target effects and toxicity suggest that these small molecules are promising lead compounds to the development of a therapy.
PubMed ID
PubMed Central ID
PMC5760851 (PMC) (EuropePMC)
Related Publication(s)
Research paper

G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo.
Simone et al., 2018, EMBO Mol. Med. 10(1): 22--31 [FBrf0237715]

Associated Information
Comments
Associated Files
Other Information
Secondary IDs
    Language of Publication
    English
    Additional Languages of Abstract
    Parent Publication
    Publication Type
    Journal
    Abbreviation
    EMBO Mol. Med.
    Title
    EMBO molecular medicine
    ISBN/ISSN
    1757-4676 1757-4684
    Data From Reference